Commonwealth Medical College, Department of Basic Sciences, Scranton, PA 18509, USA.
Expert Opin Drug Discov. 2012 Oct;7(10):863-75. doi: 10.1517/17460441.2012.714363. Epub 2012 Sep 19.
The role of lipophilicity in drug discovery and design is a critical one. Lipophilicity is a key physicochemical property that plays a crucial role in determining ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties and the overall suitability of drug candidates. There is increasing evidence to suggest that control of physicochemical properties such as lipophilicity, within a defined optimal range, can improve compound quality and the likelihood of therapeutic success.
This review focuses on understanding lipophilicity, techniques used to measure lipophilicity, and summarizes the importance of lipophilicity in drug discovery and development, including a discussion of its impact on individual ADMET parameters as well as its overall influence on the drug discovery and design process, specifically within the past 15 years.
A current review of the literature reveals a continued reliance on the synthesis of novel structures with increased potency, rather than a focus on maintaining optimal physicochemical properties associated with ADMET throughout drug optimization. Particular attention to the optimum region of lipophilicity, as well as monitoring of lipophilic efficiency indices, may contribute significantly to the overall quality of candidate drugs at different stages of discovery.
亲脂性在药物发现和设计中的作用至关重要。亲脂性是一个关键的物理化学性质,在决定药物候选物的吸收、分布、代谢、排泄和毒性(ADMET)特性以及整体适用性方面起着至关重要的作用。越来越多的证据表明,控制亲脂性等物理化学性质,使其处于定义明确的最佳范围内,可以提高化合物的质量和治疗成功的可能性。
本篇综述重点关注对亲脂性的理解、用于测量亲脂性的技术,并总结了亲脂性在药物发现和开发中的重要性,包括讨论其对个体 ADMET 参数的影响以及对药物发现和设计过程的整体影响,特别是在过去 15 年。
对文献的当前综述揭示了人们仍然依赖于合成具有更高效力的新型结构,而不是关注在药物优化过程中保持与 ADMET 相关的最佳物理化学性质。特别注意亲脂性的最佳区域,以及监测亲脂效率指数,可能会极大地提高候选药物在不同发现阶段的整体质量。